nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—PLA2G2A—atherosclerosis	0.237	0.55	CbGaD
Diclofenac—ALOX5—atherosclerosis	0.0848	0.197	CbGaD
Diclofenac—CXCL8—atherosclerosis	0.0702	0.163	CbGaD
Diclofenac—UGT2B7—Ezetimibe—atherosclerosis	0.0302	0.0811	CbGbCtD
Diclofenac—UGT2B7—Simvastatin—atherosclerosis	0.0281	0.0754	CbGbCtD
Diclofenac—UGT2B7—Lovastatin—atherosclerosis	0.0275	0.0738	CbGbCtD
Diclofenac—ABCC4—Rosuvastatin—atherosclerosis	0.0267	0.0717	CbGbCtD
Diclofenac—UGT1A1—Ezetimibe—atherosclerosis	0.0261	0.0701	CbGbCtD
Diclofenac—SLC22A11—Pravastatin—atherosclerosis	0.0261	0.07	CbGbCtD
Diclofenac—UGT1A1—Simvastatin—atherosclerosis	0.0243	0.0651	CbGbCtD
Diclofenac—UGT1A1—Lovastatin—atherosclerosis	0.0238	0.0637	CbGbCtD
Diclofenac—ABCC1—Rosuvastatin—atherosclerosis	0.0215	0.0576	CbGbCtD
Diclofenac—PTGS2—atherosclerosis	0.0205	0.0476	CbGaD
Diclofenac—ALB—atherosclerosis	0.0183	0.0424	CbGaD
Diclofenac—SLC22A8—Pravastatin—atherosclerosis	0.0152	0.0407	CbGbCtD
Diclofenac—SLC22A6—Pravastatin—atherosclerosis	0.0106	0.0284	CbGbCtD
Diclofenac—ALB—Rosuvastatin—atherosclerosis	0.00991	0.0266	CbGbCtD
Diclofenac—CYP2B6—Simvastatin—atherosclerosis	0.0094	0.0252	CbGbCtD
Diclofenac—CYP2C8—Simvastatin—atherosclerosis	0.00712	0.0191	CbGbCtD
Diclofenac—CYP2C8—Pravastatin—atherosclerosis	0.00696	0.0187	CbGbCtD
Diclofenac—CYP2C8—Lovastatin—atherosclerosis	0.00696	0.0187	CbGbCtD
Diclofenac—CYP2C19—Rosuvastatin—atherosclerosis	0.00642	0.0172	CbGbCtD
Diclofenac—CYP2C19—Simvastatin—atherosclerosis	0.00597	0.016	CbGbCtD
Diclofenac—CYP2C19—Lovastatin—atherosclerosis	0.00584	0.0157	CbGbCtD
Diclofenac—CYP2C9—Rosuvastatin—atherosclerosis	0.00534	0.0143	CbGbCtD
Diclofenac—ABCB1—Ezetimibe—atherosclerosis	0.00518	0.0139	CbGbCtD
Diclofenac—CYP2C9—Simvastatin—atherosclerosis	0.00496	0.0133	CbGbCtD
Diclofenac—CYP2C9—Lovastatin—atherosclerosis	0.00486	0.013	CbGbCtD
Diclofenac—CYP2C9—Pravastatin—atherosclerosis	0.00486	0.013	CbGbCtD
Diclofenac—ABCB1—Simvastatin—atherosclerosis	0.00482	0.0129	CbGbCtD
Diclofenac—ABCB1—Lovastatin—atherosclerosis	0.00471	0.0126	CbGbCtD
Diclofenac—ABCB1—Pravastatin—atherosclerosis	0.00471	0.0126	CbGbCtD
Diclofenac—CYP3A4—Rosuvastatin—atherosclerosis	0.0031	0.00833	CbGbCtD
Diclofenac—CYP3A4—Ezetimibe—atherosclerosis	0.0031	0.00833	CbGbCtD
Diclofenac—CYP3A4—Simvastatin—atherosclerosis	0.00289	0.00774	CbGbCtD
Diclofenac—CYP3A4—Lovastatin—atherosclerosis	0.00282	0.00758	CbGbCtD
Diclofenac—CYP3A4—Pravastatin—atherosclerosis	0.00282	0.00758	CbGbCtD
Diclofenac—CXCR1—adipose tissue—atherosclerosis	0.00115	0.0745	CbGeAlD
Diclofenac—Meclofenamic acid—ALOX5—atherosclerosis	0.000697	0.417	CrCbGaD
Diclofenac—ASIC1—adipose tissue—atherosclerosis	0.000685	0.0443	CbGeAlD
Diclofenac—PTGS2—leg—atherosclerosis	0.000646	0.0418	CbGeAlD
Diclofenac—KCNQ3—cardiovascular system—atherosclerosis	0.000617	0.04	CbGeAlD
Diclofenac—PTGS2—hindlimb—atherosclerosis	0.000577	0.0373	CbGeAlD
Diclofenac—PLA2G2A—connective tissue—atherosclerosis	0.000538	0.0348	CbGeAlD
Diclofenac—PTGS2—appendage—atherosclerosis	0.000495	0.032	CbGeAlD
Diclofenac—PLA2G2A—cardiovascular system—atherosclerosis	0.000468	0.0303	CbGeAlD
Diclofenac—PLA2G2A—adipose tissue—atherosclerosis	0.000413	0.0267	CbGeAlD
Diclofenac—CXCL8—adipose tissue—atherosclerosis	0.000409	0.0265	CbGeAlD
Diclofenac—TTR—connective tissue—atherosclerosis	0.000406	0.0263	CbGeAlD
Diclofenac—PTGS1—artery—atherosclerosis	0.00037	0.0239	CbGeAlD
Diclofenac—ALOX5—connective tissue—atherosclerosis	0.000368	0.0238	CbGeAlD
Diclofenac—PTGS2—artery—atherosclerosis	0.000353	0.0229	CbGeAlD
Diclofenac—TTR—cardiovascular system—atherosclerosis	0.000353	0.0229	CbGeAlD
Diclofenac—SLCO1C1—adipose tissue—atherosclerosis	0.000349	0.0226	CbGeAlD
Diclofenac—SCN4A—adipose tissue—atherosclerosis	0.00032	0.0207	CbGeAlD
Diclofenac—ALOX5—cardiovascular system—atherosclerosis	0.00032	0.0207	CbGeAlD
Diclofenac—PTGS1—endothelium—atherosclerosis	0.000312	0.0202	CbGeAlD
Diclofenac—PTGS2—endothelium—atherosclerosis	0.000299	0.0193	CbGeAlD
Diclofenac—PLA2G2A—liver—atherosclerosis	0.000289	0.0187	CbGeAlD
Diclofenac—PTGS1—blood vessel—atherosclerosis	0.000288	0.0187	CbGeAlD
Diclofenac—CXCL8—liver—atherosclerosis	0.000286	0.0186	CbGeAlD
Diclofenac—ALOX5—adipose tissue—atherosclerosis	0.000282	0.0183	CbGeAlD
Diclofenac—PTGS2—blood vessel—atherosclerosis	0.000275	0.0178	CbGeAlD
Diclofenac—CYP2C18—liver—atherosclerosis	0.000264	0.0171	CbGeAlD
Diclofenac—Bromfenac—PTGS2—atherosclerosis	0.000254	0.152	CrCbGaD
Diclofenac—UGT2B7—liver—atherosclerosis	0.000244	0.0158	CbGeAlD
Diclofenac—SLC22A11—liver—atherosclerosis	0.000237	0.0154	CbGeAlD
Diclofenac—TTR—liver—atherosclerosis	0.000218	0.0141	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—atherosclerosis	0.000216	0.129	CrCbGaD
Diclofenac—UGT1A1—liver—atherosclerosis	0.000207	0.0134	CbGeAlD
Diclofenac—Nepafenac—PTGS2—atherosclerosis	0.000205	0.123	CrCbGaD
Diclofenac—ALOX5—liver—atherosclerosis	0.000198	0.0128	CbGeAlD
Diclofenac—ABCC4—adipose tissue—atherosclerosis	0.000192	0.0125	CbGeAlD
Diclofenac—ABCB1—blood vessel—atherosclerosis	0.00017	0.011	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—atherosclerosis	0.000168	0.101	CrCbGaD
Diclofenac—ABCC1—adipose tissue—atherosclerosis	0.000164	0.0106	CbGeAlD
Diclofenac—PTGS1—connective tissue—atherosclerosis	0.000148	0.00956	CbGeAlD
Diclofenac—CYP2B6—cardiovascular system—atherosclerosis	0.000142	0.0092	CbGeAlD
Diclofenac—PTGS2—connective tissue—atherosclerosis	0.000141	0.00914	CbGeAlD
Diclofenac—CYP2C9—cardiovascular system—atherosclerosis	0.000141	0.00911	CbGeAlD
Diclofenac—ALB—liver—atherosclerosis	0.000139	0.00903	CbGeAlD
Diclofenac—ABCC4—liver—atherosclerosis	0.000135	0.00874	CbGeAlD
Diclofenac—CYP2E1—cardiovascular system—atherosclerosis	0.000133	0.00864	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—atherosclerosis	0.000131	0.0783	CrCbGaD
Diclofenac—CYP1A1—adipose tissue—atherosclerosis	0.000129	0.00835	CbGeAlD
Diclofenac—PTGS1—cardiovascular system—atherosclerosis	0.000129	0.00832	CbGeAlD
Diclofenac—PTGS2—cardiovascular system—atherosclerosis	0.000123	0.00795	CbGeAlD
Diclofenac—Muscle spasms—Simvastatin—atherosclerosis	0.000117	0.00124	CcSEcCtD
Diclofenac—Vertigo—Lovastatin—atherosclerosis	0.000117	0.00124	CcSEcCtD
Diclofenac—Angioedema—Ezetimibe—atherosclerosis	0.000117	0.00124	CcSEcCtD
Diclofenac—Angiopathy—Niacin—atherosclerosis	0.000116	0.00124	CcSEcCtD
Diclofenac—Leukopenia—Lovastatin—atherosclerosis	0.000116	0.00124	CcSEcCtD
Diclofenac—ABCC1—liver—atherosclerosis	0.000115	0.00745	CbGeAlD
Diclofenac—Chills—Niacin—atherosclerosis	0.000115	0.00122	CcSEcCtD
Diclofenac—Malaise—Ezetimibe—atherosclerosis	0.000115	0.00122	CcSEcCtD
Diclofenac—Vision blurred—Simvastatin—atherosclerosis	0.000115	0.00122	CcSEcCtD
Diclofenac—Arrhythmia—Niacin—atherosclerosis	0.000115	0.00122	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000114	0.00121	CcSEcCtD
Diclofenac—Tremor—Simvastatin—atherosclerosis	0.000114	0.00121	CcSEcCtD
Diclofenac—Alopecia—Niacin—atherosclerosis	0.000113	0.0012	CcSEcCtD
Diclofenac—Chills—Pravastatin—atherosclerosis	0.000113	0.0012	CcSEcCtD
Diclofenac—PTGS1—adipose tissue—atherosclerosis	0.000113	0.00734	CbGeAlD
Diclofenac—Insomnia—Rosuvastatin—atherosclerosis	0.000113	0.0012	CcSEcCtD
Diclofenac—Ill-defined disorder—Simvastatin—atherosclerosis	0.000113	0.0012	CcSEcCtD
Diclofenac—Arrhythmia—Pravastatin—atherosclerosis	0.000113	0.0012	CcSEcCtD
Diclofenac—Palpitations—Ezetimibe—atherosclerosis	0.000113	0.0012	CcSEcCtD
Diclofenac—Paraesthesia—Rosuvastatin—atherosclerosis	0.000112	0.00119	CcSEcCtD
Diclofenac—Anaemia—Simvastatin—atherosclerosis	0.000112	0.00119	CcSEcCtD
Diclofenac—CYP2C19—liver—atherosclerosis	0.000112	0.00727	CbGeAlD
Diclofenac—Erythema—Niacin—atherosclerosis	0.000112	0.00119	CcSEcCtD
Diclofenac—Malnutrition—Niacin—atherosclerosis	0.000112	0.00119	CcSEcCtD
Diclofenac—Alopecia—Pravastatin—atherosclerosis	0.000112	0.00119	CcSEcCtD
Diclofenac—Cough—Ezetimibe—atherosclerosis	0.000111	0.00118	CcSEcCtD
Diclofenac—Angioedema—Simvastatin—atherosclerosis	0.000111	0.00118	CcSEcCtD
Diclofenac—Myalgia—Lovastatin—atherosclerosis	0.000111	0.00118	CcSEcCtD
Diclofenac—Chest pain—Lovastatin—atherosclerosis	0.000111	0.00118	CcSEcCtD
Diclofenac—Arthralgia—Lovastatin—atherosclerosis	0.000111	0.00118	CcSEcCtD
Diclofenac—Anxiety—Lovastatin—atherosclerosis	0.00011	0.00117	CcSEcCtD
Diclofenac—Dyspepsia—Rosuvastatin—atherosclerosis	0.00011	0.00117	CcSEcCtD
Diclofenac—Hypertension—Ezetimibe—atherosclerosis	0.00011	0.00117	CcSEcCtD
Diclofenac—Flatulence—Niacin—atherosclerosis	0.00011	0.00117	CcSEcCtD
Diclofenac—Malaise—Simvastatin—atherosclerosis	0.00011	0.00116	CcSEcCtD
Diclofenac—Tension—Niacin—atherosclerosis	0.00011	0.00116	CcSEcCtD
Diclofenac—Discomfort—Lovastatin—atherosclerosis	0.000109	0.00116	CcSEcCtD
Diclofenac—Vertigo—Simvastatin—atherosclerosis	0.000109	0.00116	CcSEcCtD
Diclofenac—Leukopenia—Simvastatin—atherosclerosis	0.000109	0.00116	CcSEcCtD
Diclofenac—Arthralgia—Ezetimibe—atherosclerosis	0.000109	0.00115	CcSEcCtD
Diclofenac—Chest pain—Ezetimibe—atherosclerosis	0.000109	0.00115	CcSEcCtD
Diclofenac—Myalgia—Ezetimibe—atherosclerosis	0.000109	0.00115	CcSEcCtD
Diclofenac—Nervousness—Niacin—atherosclerosis	0.000108	0.00115	CcSEcCtD
Diclofenac—Flatulence—Pravastatin—atherosclerosis	0.000108	0.00115	CcSEcCtD
Diclofenac—PTGS2—adipose tissue—atherosclerosis	0.000108	0.00701	CbGeAlD
Diclofenac—Dry mouth—Lovastatin—atherosclerosis	0.000108	0.00115	CcSEcCtD
Diclofenac—Tension—Pravastatin—atherosclerosis	0.000108	0.00115	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000108	0.00114	CcSEcCtD
Diclofenac—Dysgeusia—Pravastatin—atherosclerosis	0.000108	0.00114	CcSEcCtD
Diclofenac—Muscle spasms—Niacin—atherosclerosis	0.000107	0.00114	CcSEcCtD
Diclofenac—Discomfort—Ezetimibe—atherosclerosis	0.000107	0.00114	CcSEcCtD
Diclofenac—Pain—Rosuvastatin—atherosclerosis	0.000107	0.00114	CcSEcCtD
Diclofenac—Constipation—Rosuvastatin—atherosclerosis	0.000107	0.00114	CcSEcCtD
Diclofenac—Confusional state—Lovastatin—atherosclerosis	0.000107	0.00114	CcSEcCtD
Diclofenac—Nervousness—Pravastatin—atherosclerosis	0.000107	0.00113	CcSEcCtD
Diclofenac—Dry mouth—Ezetimibe—atherosclerosis	0.000106	0.00113	CcSEcCtD
Diclofenac—Anaphylactic shock—Lovastatin—atherosclerosis	0.000106	0.00113	CcSEcCtD
Diclofenac—Muscle spasms—Pravastatin—atherosclerosis	0.000106	0.00112	CcSEcCtD
Diclofenac—Infection—Lovastatin—atherosclerosis	0.000105	0.00112	CcSEcCtD
Diclofenac—Vision blurred—Niacin—atherosclerosis	0.000105	0.00112	CcSEcCtD
Diclofenac—Confusional state—Ezetimibe—atherosclerosis	0.000105	0.00111	CcSEcCtD
Diclofenac—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000104	0.00111	CcSEcCtD
Diclofenac—Thrombocytopenia—Lovastatin—atherosclerosis	0.000104	0.0011	CcSEcCtD
Diclofenac—Vision blurred—Pravastatin—atherosclerosis	0.000104	0.0011	CcSEcCtD
Diclofenac—Chest pain—Simvastatin—atherosclerosis	0.000104	0.0011	CcSEcCtD
Diclofenac—Myalgia—Simvastatin—atherosclerosis	0.000104	0.0011	CcSEcCtD
Diclofenac—Arthralgia—Simvastatin—atherosclerosis	0.000104	0.0011	CcSEcCtD
Diclofenac—Infection—Ezetimibe—atherosclerosis	0.000103	0.0011	CcSEcCtD
Diclofenac—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000103	0.0011	CcSEcCtD
Diclofenac—Anxiety—Simvastatin—atherosclerosis	0.000103	0.0011	CcSEcCtD
Diclofenac—Tremor—Pravastatin—atherosclerosis	0.000103	0.00109	CcSEcCtD
Diclofenac—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000102	0.00109	CcSEcCtD
Diclofenac—Discomfort—Simvastatin—atherosclerosis	0.000102	0.00109	CcSEcCtD
Diclofenac—Nervous system disorder—Ezetimibe—atherosclerosis	0.000102	0.00108	CcSEcCtD
Diclofenac—Angioedema—Niacin—atherosclerosis	0.000102	0.00108	CcSEcCtD
Diclofenac—Ill-defined disorder—Pravastatin—atherosclerosis	0.000102	0.00108	CcSEcCtD
Diclofenac—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000102	0.00108	CcSEcCtD
Diclofenac—Anaemia—Pravastatin—atherosclerosis	0.000102	0.00108	CcSEcCtD
Diclofenac—Anorexia—Lovastatin—atherosclerosis	0.000101	0.00107	CcSEcCtD
Diclofenac—Skin disorder—Ezetimibe—atherosclerosis	0.000101	0.00107	CcSEcCtD
Diclofenac—Angioedema—Pravastatin—atherosclerosis	0.0001	0.00107	CcSEcCtD
Diclofenac—Vertigo—Niacin—atherosclerosis	0.0001	0.00107	CcSEcCtD
Diclofenac—Syncope—Niacin—atherosclerosis	0.0001	0.00106	CcSEcCtD
Diclofenac—Confusional state—Simvastatin—atherosclerosis	0.0001	0.00106	CcSEcCtD
Diclofenac—Leukopenia—Niacin—atherosclerosis	0.0001	0.00106	CcSEcCtD
Diclofenac—Urticaria—Rosuvastatin—atherosclerosis	9.95e-05	0.00106	CcSEcCtD
Diclofenac—Oedema—Simvastatin—atherosclerosis	9.93e-05	0.00105	CcSEcCtD
Diclofenac—Anaphylactic shock—Simvastatin—atherosclerosis	9.93e-05	0.00105	CcSEcCtD
Diclofenac—Malaise—Pravastatin—atherosclerosis	9.91e-05	0.00105	CcSEcCtD
Diclofenac—Abdominal pain—Rosuvastatin—atherosclerosis	9.9e-05	0.00105	CcSEcCtD
Diclofenac—Vertigo—Pravastatin—atherosclerosis	9.88e-05	0.00105	CcSEcCtD
Diclofenac—Palpitations—Niacin—atherosclerosis	9.87e-05	0.00105	CcSEcCtD
Diclofenac—Infection—Simvastatin—atherosclerosis	9.86e-05	0.00105	CcSEcCtD
Diclofenac—Leukopenia—Pravastatin—atherosclerosis	9.84e-05	0.00105	CcSEcCtD
Diclofenac—Loss of consciousness—Niacin—atherosclerosis	9.81e-05	0.00104	CcSEcCtD
Diclofenac—CYP2C8—liver—atherosclerosis	9.8e-05	0.00635	CbGeAlD
Diclofenac—Cough—Niacin—atherosclerosis	9.74e-05	0.00103	CcSEcCtD
Diclofenac—Thrombocytopenia—Simvastatin—atherosclerosis	9.72e-05	0.00103	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Lovastatin—atherosclerosis	9.67e-05	0.00103	CcSEcCtD
Diclofenac—Insomnia—Lovastatin—atherosclerosis	9.6e-05	0.00102	CcSEcCtD
Diclofenac—Cough—Pravastatin—atherosclerosis	9.59e-05	0.00102	CcSEcCtD
Diclofenac—Paraesthesia—Lovastatin—atherosclerosis	9.53e-05	0.00101	CcSEcCtD
Diclofenac—Arthralgia—Niacin—atherosclerosis	9.51e-05	0.00101	CcSEcCtD
Diclofenac—Myalgia—Niacin—atherosclerosis	9.51e-05	0.00101	CcSEcCtD
Diclofenac—Hypertension—Pravastatin—atherosclerosis	9.49e-05	0.00101	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	9.48e-05	0.00101	CcSEcCtD
Diclofenac—Anorexia—Simvastatin—atherosclerosis	9.46e-05	0.001	CcSEcCtD
Diclofenac—Dyspnoea—Lovastatin—atherosclerosis	9.46e-05	0.001	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	9.44e-05	0.001	CcSEcCtD
Diclofenac—Insomnia—Ezetimibe—atherosclerosis	9.41e-05	0.001	CcSEcCtD
Diclofenac—Arthralgia—Pravastatin—atherosclerosis	9.36e-05	0.000994	CcSEcCtD
Diclofenac—Myalgia—Pravastatin—atherosclerosis	9.36e-05	0.000994	CcSEcCtD
Diclofenac—Chest pain—Pravastatin—atherosclerosis	9.36e-05	0.000994	CcSEcCtD
Diclofenac—Paraesthesia—Ezetimibe—atherosclerosis	9.35e-05	0.000992	CcSEcCtD
Diclofenac—Dyspepsia—Lovastatin—atherosclerosis	9.34e-05	0.000992	CcSEcCtD
Diclofenac—Anxiety—Pravastatin—atherosclerosis	9.33e-05	0.00099	CcSEcCtD
Diclofenac—Dry mouth—Niacin—atherosclerosis	9.3e-05	0.000987	CcSEcCtD
Diclofenac—Dyspnoea—Ezetimibe—atherosclerosis	9.28e-05	0.000985	CcSEcCtD
Diclofenac—Discomfort—Pravastatin—atherosclerosis	9.25e-05	0.000982	CcSEcCtD
Diclofenac—Hypersensitivity—Rosuvastatin—atherosclerosis	9.22e-05	0.00098	CcSEcCtD
Diclofenac—Decreased appetite—Lovastatin—atherosclerosis	9.22e-05	0.000979	CcSEcCtD
Diclofenac—CYP1A2—liver—atherosclerosis	9.17e-05	0.00594	CbGeAlD
Diclofenac—Dyspepsia—Ezetimibe—atherosclerosis	9.16e-05	0.000973	CcSEcCtD
Diclofenac—Fatigue—Lovastatin—atherosclerosis	9.15e-05	0.000971	CcSEcCtD
Diclofenac—Oedema—Niacin—atherosclerosis	9.11e-05	0.000968	CcSEcCtD
Diclofenac—Anaphylactic shock—Niacin—atherosclerosis	9.11e-05	0.000968	CcSEcCtD
Diclofenac—Pain—Lovastatin—atherosclerosis	9.07e-05	0.000964	CcSEcCtD
Diclofenac—Constipation—Lovastatin—atherosclerosis	9.07e-05	0.000964	CcSEcCtD
Diclofenac—Confusional state—Pravastatin—atherosclerosis	9.05e-05	0.000961	CcSEcCtD
Diclofenac—Decreased appetite—Ezetimibe—atherosclerosis	9.05e-05	0.000961	CcSEcCtD
Diclofenac—CYP1A1—liver—atherosclerosis	9.05e-05	0.00586	CbGeAlD
Diclofenac—Musculoskeletal discomfort—Simvastatin—atherosclerosis	9.04e-05	0.00096	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Ezetimibe—atherosclerosis	8.99e-05	0.000954	CcSEcCtD
Diclofenac—Asthenia—Rosuvastatin—atherosclerosis	8.98e-05	0.000954	CcSEcCtD
Diclofenac—Insomnia—Simvastatin—atherosclerosis	8.98e-05	0.000953	CcSEcCtD
Diclofenac—Oedema—Pravastatin—atherosclerosis	8.97e-05	0.000953	CcSEcCtD
Diclofenac—Anaphylactic shock—Pravastatin—atherosclerosis	8.97e-05	0.000953	CcSEcCtD
Diclofenac—Fatigue—Ezetimibe—atherosclerosis	8.97e-05	0.000953	CcSEcCtD
Diclofenac—Shock—Niacin—atherosclerosis	8.97e-05	0.000952	CcSEcCtD
Diclofenac—Infection—Pravastatin—atherosclerosis	8.91e-05	0.000947	CcSEcCtD
Diclofenac—Paraesthesia—Simvastatin—atherosclerosis	8.91e-05	0.000946	CcSEcCtD
Diclofenac—Pain—Ezetimibe—atherosclerosis	8.9e-05	0.000945	CcSEcCtD
Diclofenac—Constipation—Ezetimibe—atherosclerosis	8.9e-05	0.000945	CcSEcCtD
Diclofenac—Tachycardia—Niacin—atherosclerosis	8.89e-05	0.000944	CcSEcCtD
Diclofenac—Pruritus—Rosuvastatin—atherosclerosis	8.86e-05	0.000941	CcSEcCtD
Diclofenac—Skin disorder—Niacin—atherosclerosis	8.85e-05	0.00094	CcSEcCtD
Diclofenac—Dyspnoea—Simvastatin—atherosclerosis	8.85e-05	0.00094	CcSEcCtD
Diclofenac—Hyperhidrosis—Niacin—atherosclerosis	8.81e-05	0.000936	CcSEcCtD
Diclofenac—CYP2B6—liver—atherosclerosis	8.79e-05	0.00569	CbGeAlD
Diclofenac—Thrombocytopenia—Pravastatin—atherosclerosis	8.79e-05	0.000933	CcSEcCtD
Diclofenac—Feeling abnormal—Lovastatin—atherosclerosis	8.74e-05	0.000928	CcSEcCtD
Diclofenac—Dyspepsia—Simvastatin—atherosclerosis	8.74e-05	0.000928	CcSEcCtD
Diclofenac—CYP2C9—liver—atherosclerosis	8.7e-05	0.00564	CbGeAlD
Diclofenac—Anorexia—Niacin—atherosclerosis	8.69e-05	0.000922	CcSEcCtD
Diclofenac—Gastrointestinal pain—Lovastatin—atherosclerosis	8.68e-05	0.000921	CcSEcCtD
Diclofenac—Hyperhidrosis—Pravastatin—atherosclerosis	8.67e-05	0.000921	CcSEcCtD
Diclofenac—Decreased appetite—Simvastatin—atherosclerosis	8.63e-05	0.000916	CcSEcCtD
Diclofenac—Feeling abnormal—Ezetimibe—atherosclerosis	8.58e-05	0.000911	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Simvastatin—atherosclerosis	8.57e-05	0.00091	CcSEcCtD
Diclofenac—Diarrhoea—Rosuvastatin—atherosclerosis	8.57e-05	0.00091	CcSEcCtD
Diclofenac—Fatigue—Simvastatin—atherosclerosis	8.56e-05	0.000909	CcSEcCtD
Diclofenac—Anorexia—Pravastatin—atherosclerosis	8.55e-05	0.000908	CcSEcCtD
Diclofenac—Hypotension—Niacin—atherosclerosis	8.52e-05	0.000904	CcSEcCtD
Diclofenac—Gastrointestinal pain—Ezetimibe—atherosclerosis	8.51e-05	0.000904	CcSEcCtD
Diclofenac—Pain—Simvastatin—atherosclerosis	8.49e-05	0.000901	CcSEcCtD
Diclofenac—Constipation—Simvastatin—atherosclerosis	8.49e-05	0.000901	CcSEcCtD
Diclofenac—Urticaria—Lovastatin—atherosclerosis	8.43e-05	0.000895	CcSEcCtD
Diclofenac—Abdominal pain—Lovastatin—atherosclerosis	8.39e-05	0.000891	CcSEcCtD
Diclofenac—Body temperature increased—Lovastatin—atherosclerosis	8.39e-05	0.000891	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Niacin—atherosclerosis	8.3e-05	0.000882	CcSEcCtD
Diclofenac—Dizziness—Rosuvastatin—atherosclerosis	8.28e-05	0.000879	CcSEcCtD
Diclofenac—Urticaria—Ezetimibe—atherosclerosis	8.27e-05	0.000878	CcSEcCtD
Diclofenac—CYP2E1—liver—atherosclerosis	8.25e-05	0.00534	CbGeAlD
Diclofenac—Insomnia—Niacin—atherosclerosis	8.24e-05	0.000875	CcSEcCtD
Diclofenac—Body temperature increased—Ezetimibe—atherosclerosis	8.23e-05	0.000874	CcSEcCtD
Diclofenac—Abdominal pain—Ezetimibe—atherosclerosis	8.23e-05	0.000874	CcSEcCtD
Diclofenac—Paraesthesia—Niacin—atherosclerosis	8.18e-05	0.000869	CcSEcCtD
Diclofenac—Feeling abnormal—Simvastatin—atherosclerosis	8.18e-05	0.000868	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Pravastatin—atherosclerosis	8.18e-05	0.000868	CcSEcCtD
Diclofenac—Dyspnoea—Niacin—atherosclerosis	8.12e-05	0.000863	CcSEcCtD
Diclofenac—Gastrointestinal pain—Simvastatin—atherosclerosis	8.12e-05	0.000862	CcSEcCtD
Diclofenac—Insomnia—Pravastatin—atherosclerosis	8.12e-05	0.000862	CcSEcCtD
Diclofenac—Somnolence—Niacin—atherosclerosis	8.1e-05	0.00086	CcSEcCtD
Diclofenac—Paraesthesia—Pravastatin—atherosclerosis	8.06e-05	0.000856	CcSEcCtD
Diclofenac—Dyspepsia—Niacin—atherosclerosis	8.02e-05	0.000852	CcSEcCtD
Diclofenac—Dyspnoea—Pravastatin—atherosclerosis	8e-05	0.000849	CcSEcCtD
Diclofenac—Decreased appetite—Niacin—atherosclerosis	7.92e-05	0.000841	CcSEcCtD
Diclofenac—Dyspepsia—Pravastatin—atherosclerosis	7.9e-05	0.000839	CcSEcCtD
Diclofenac—Rash—Rosuvastatin—atherosclerosis	7.89e-05	0.000838	CcSEcCtD
Diclofenac—Dermatitis—Rosuvastatin—atherosclerosis	7.89e-05	0.000838	CcSEcCtD
Diclofenac—Urticaria—Simvastatin—atherosclerosis	7.88e-05	0.000837	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Niacin—atherosclerosis	7.87e-05	0.000835	CcSEcCtD
Diclofenac—Body temperature increased—Simvastatin—atherosclerosis	7.85e-05	0.000833	CcSEcCtD
Diclofenac—Abdominal pain—Simvastatin—atherosclerosis	7.85e-05	0.000833	CcSEcCtD
Diclofenac—Headache—Rosuvastatin—atherosclerosis	7.84e-05	0.000833	CcSEcCtD
Diclofenac—Hypersensitivity—Lovastatin—atherosclerosis	7.82e-05	0.00083	CcSEcCtD
Diclofenac—Decreased appetite—Pravastatin—atherosclerosis	7.8e-05	0.000828	CcSEcCtD
Diclofenac—Pain—Niacin—atherosclerosis	7.79e-05	0.000828	CcSEcCtD
Diclofenac—Fatigue—Pravastatin—atherosclerosis	7.74e-05	0.000821	CcSEcCtD
Diclofenac—Pain—Pravastatin—atherosclerosis	7.67e-05	0.000815	CcSEcCtD
Diclofenac—Constipation—Pravastatin—atherosclerosis	7.67e-05	0.000815	CcSEcCtD
Diclofenac—Hypersensitivity—Ezetimibe—atherosclerosis	7.67e-05	0.000814	CcSEcCtD
Diclofenac—Asthenia—Lovastatin—atherosclerosis	7.61e-05	0.000808	CcSEcCtD
Diclofenac—ABCB1—cardiovascular system—atherosclerosis	7.6e-05	0.00492	CbGeAlD
Diclofenac—PTGS2—liver—atherosclerosis	7.6e-05	0.00492	CbGeAlD
Diclofenac—Pruritus—Lovastatin—atherosclerosis	7.51e-05	0.000797	CcSEcCtD
Diclofenac—Asthenia—Ezetimibe—atherosclerosis	7.47e-05	0.000793	CcSEcCtD
Diclofenac—Gastrointestinal pain—Niacin—atherosclerosis	7.45e-05	0.000791	CcSEcCtD
Diclofenac—Nausea—Rosuvastatin—atherosclerosis	7.44e-05	0.00079	CcSEcCtD
Diclofenac—Feeling abnormal—Pravastatin—atherosclerosis	7.39e-05	0.000785	CcSEcCtD
Diclofenac—Pruritus—Ezetimibe—atherosclerosis	7.36e-05	0.000782	CcSEcCtD
Diclofenac—Gastrointestinal pain—Pravastatin—atherosclerosis	7.34e-05	0.000779	CcSEcCtD
Diclofenac—Hypersensitivity—Simvastatin—atherosclerosis	7.31e-05	0.000776	CcSEcCtD
Diclofenac—Diarrhoea—Lovastatin—atherosclerosis	7.26e-05	0.000771	CcSEcCtD
Diclofenac—Urticaria—Niacin—atherosclerosis	7.24e-05	0.000769	CcSEcCtD
Diclofenac—Abdominal pain—Niacin—atherosclerosis	7.2e-05	0.000765	CcSEcCtD
Diclofenac—Body temperature increased—Niacin—atherosclerosis	7.2e-05	0.000765	CcSEcCtD
Diclofenac—Urticaria—Pravastatin—atherosclerosis	7.13e-05	0.000757	CcSEcCtD
Diclofenac—Asthenia—Simvastatin—atherosclerosis	7.12e-05	0.000756	CcSEcCtD
Diclofenac—Diarrhoea—Ezetimibe—atherosclerosis	7.12e-05	0.000756	CcSEcCtD
Diclofenac—Abdominal pain—Pravastatin—atherosclerosis	7.09e-05	0.000753	CcSEcCtD
Diclofenac—Body temperature increased—Pravastatin—atherosclerosis	7.09e-05	0.000753	CcSEcCtD
Diclofenac—Pruritus—Simvastatin—atherosclerosis	7.02e-05	0.000746	CcSEcCtD
Diclofenac—Dizziness—Lovastatin—atherosclerosis	7.02e-05	0.000745	CcSEcCtD
Diclofenac—Dizziness—Ezetimibe—atherosclerosis	6.88e-05	0.000731	CcSEcCtD
Diclofenac—Diarrhoea—Simvastatin—atherosclerosis	6.79e-05	0.000721	CcSEcCtD
Diclofenac—Vomiting—Lovastatin—atherosclerosis	6.75e-05	0.000716	CcSEcCtD
Diclofenac—Hypersensitivity—Niacin—atherosclerosis	6.71e-05	0.000713	CcSEcCtD
Diclofenac—ABCB1—adipose tissue—atherosclerosis	6.7e-05	0.00434	CbGeAlD
Diclofenac—Rash—Lovastatin—atherosclerosis	6.69e-05	0.00071	CcSEcCtD
Diclofenac—Dermatitis—Lovastatin—atherosclerosis	6.68e-05	0.00071	CcSEcCtD
Diclofenac—Headache—Lovastatin—atherosclerosis	6.65e-05	0.000706	CcSEcCtD
Diclofenac—CYP3A4—liver—atherosclerosis	6.64e-05	0.0043	CbGeAlD
Diclofenac—Vomiting—Ezetimibe—atherosclerosis	6.62e-05	0.000703	CcSEcCtD
Diclofenac—Hypersensitivity—Pravastatin—atherosclerosis	6.61e-05	0.000702	CcSEcCtD
Diclofenac—Dizziness—Simvastatin—atherosclerosis	6.56e-05	0.000697	CcSEcCtD
Diclofenac—Rash—Ezetimibe—atherosclerosis	6.56e-05	0.000697	CcSEcCtD
Diclofenac—Dermatitis—Ezetimibe—atherosclerosis	6.56e-05	0.000696	CcSEcCtD
Diclofenac—Asthenia—Niacin—atherosclerosis	6.54e-05	0.000694	CcSEcCtD
Diclofenac—Headache—Ezetimibe—atherosclerosis	6.52e-05	0.000692	CcSEcCtD
Diclofenac—Pruritus—Niacin—atherosclerosis	6.45e-05	0.000685	CcSEcCtD
Diclofenac—Asthenia—Pravastatin—atherosclerosis	6.44e-05	0.000684	CcSEcCtD
Diclofenac—Pruritus—Pravastatin—atherosclerosis	6.35e-05	0.000674	CcSEcCtD
Diclofenac—Vomiting—Simvastatin—atherosclerosis	6.31e-05	0.00067	CcSEcCtD
Diclofenac—Nausea—Lovastatin—atherosclerosis	6.3e-05	0.000669	CcSEcCtD
Diclofenac—Rash—Simvastatin—atherosclerosis	6.26e-05	0.000665	CcSEcCtD
Diclofenac—Dermatitis—Simvastatin—atherosclerosis	6.25e-05	0.000664	CcSEcCtD
Diclofenac—Diarrhoea—Niacin—atherosclerosis	6.24e-05	0.000662	CcSEcCtD
Diclofenac—Headache—Simvastatin—atherosclerosis	6.22e-05	0.00066	CcSEcCtD
Diclofenac—Nausea—Ezetimibe—atherosclerosis	6.18e-05	0.000656	CcSEcCtD
Diclofenac—Diarrhoea—Pravastatin—atherosclerosis	6.14e-05	0.000652	CcSEcCtD
Diclofenac—Dizziness—Niacin—atherosclerosis	6.03e-05	0.00064	CcSEcCtD
Diclofenac—Dizziness—Pravastatin—atherosclerosis	5.93e-05	0.00063	CcSEcCtD
Diclofenac—Nausea—Simvastatin—atherosclerosis	5.9e-05	0.000626	CcSEcCtD
Diclofenac—Vomiting—Niacin—atherosclerosis	5.79e-05	0.000615	CcSEcCtD
Diclofenac—Rash—Niacin—atherosclerosis	5.75e-05	0.00061	CcSEcCtD
Diclofenac—Dermatitis—Niacin—atherosclerosis	5.74e-05	0.00061	CcSEcCtD
Diclofenac—Headache—Niacin—atherosclerosis	5.71e-05	0.000606	CcSEcCtD
Diclofenac—Vomiting—Pravastatin—atherosclerosis	5.71e-05	0.000606	CcSEcCtD
Diclofenac—Rash—Pravastatin—atherosclerosis	5.66e-05	0.000601	CcSEcCtD
Diclofenac—Dermatitis—Pravastatin—atherosclerosis	5.65e-05	0.0006	CcSEcCtD
Diclofenac—Headache—Pravastatin—atherosclerosis	5.62e-05	0.000597	CcSEcCtD
Diclofenac—Nausea—Niacin—atherosclerosis	5.41e-05	0.000575	CcSEcCtD
Diclofenac—Nausea—Pravastatin—atherosclerosis	5.33e-05	0.000566	CcSEcCtD
Diclofenac—ABCB1—liver—atherosclerosis	4.7e-05	0.00304	CbGeAlD
Diclofenac—CYP2E1—Metabolism—GPX1—atherosclerosis	1.74e-06	2.04e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—LDLR—atherosclerosis	1.74e-06	2.03e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CD36—atherosclerosis	1.73e-06	2.03e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTM1—atherosclerosis	1.71e-06	2.01e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ABCA1—atherosclerosis	1.71e-06	2e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—atherosclerosis	1.71e-06	2e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—INS—atherosclerosis	1.71e-06	2e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—LPA—atherosclerosis	1.71e-06	2e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—MTHFR—atherosclerosis	1.71e-06	2e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CETP—atherosclerosis	1.7e-06	1.98e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CD36—atherosclerosis	1.69e-06	1.98e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—atherosclerosis	1.69e-06	1.98e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.69e-06	1.97e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—atherosclerosis	1.68e-06	1.97e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—LPL—atherosclerosis	1.68e-06	1.97e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—HMOX1—atherosclerosis	1.68e-06	1.96e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARA—atherosclerosis	1.67e-06	1.96e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—BGN—atherosclerosis	1.65e-06	1.94e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GPX1—atherosclerosis	1.64e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—MTHFR—atherosclerosis	1.64e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOA5—atherosclerosis	1.64e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—atherosclerosis	1.64e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.62e-06	1.9e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—atherosclerosis	1.62e-06	1.9e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AGT—atherosclerosis	1.62e-06	1.9e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—atherosclerosis	1.62e-06	1.9e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—INS—atherosclerosis	1.62e-06	1.9e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.62e-06	1.89e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK3—atherosclerosis	1.62e-06	1.89e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—APOB—atherosclerosis	1.61e-06	1.89e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARA—atherosclerosis	1.61e-06	1.88e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.61e-06	1.88e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—APOB—atherosclerosis	1.61e-06	1.88e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.6e-06	1.87e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CD36—atherosclerosis	1.6e-06	1.87e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—atherosclerosis	1.59e-06	1.86e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—APOE—atherosclerosis	1.59e-06	1.86e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.58e-06	1.85e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARA—atherosclerosis	1.58e-06	1.84e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.58e-06	1.84e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CAV1—atherosclerosis	1.57e-06	1.84e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.57e-06	1.84e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—APOA1—atherosclerosis	1.57e-06	1.84e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TGFB1—atherosclerosis	1.57e-06	1.84e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ALB—atherosclerosis	1.57e-06	1.83e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTM1—atherosclerosis	1.56e-06	1.83e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AGT—atherosclerosis	1.56e-06	1.82e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—atherosclerosis	1.56e-06	1.82e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK3—atherosclerosis	1.55e-06	1.81e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—LPL—atherosclerosis	1.54e-06	1.8e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.53e-06	1.79e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—LPL—atherosclerosis	1.53e-06	1.79e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—APOE—atherosclerosis	1.53e-06	1.79e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AGT—atherosclerosis	1.53e-06	1.79e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.52e-06	1.78e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—MTHFR—atherosclerosis	1.51e-06	1.77e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CAV1—atherosclerosis	1.51e-06	1.77e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—atherosclerosis	1.51e-06	1.77e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—APOA1—atherosclerosis	1.51e-06	1.77e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.5e-06	1.76e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GPX1—atherosclerosis	1.5e-06	1.76e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFB1—atherosclerosis	1.5e-06	1.76e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—NOS3—atherosclerosis	1.5e-06	1.75e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GPX1—atherosclerosis	1.5e-06	1.75e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—APOE—atherosclerosis	1.49e-06	1.75e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SERPINE1—atherosclerosis	1.49e-06	1.74e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARA—atherosclerosis	1.49e-06	1.74e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CAV1—atherosclerosis	1.48e-06	1.73e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—APOA1—atherosclerosis	1.48e-06	1.73e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—HMOX1—atherosclerosis	1.47e-06	1.72e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CD36—atherosclerosis	1.46e-06	1.72e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CD36—atherosclerosis	1.46e-06	1.71e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK3—atherosclerosis	1.44e-06	1.69e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—APOB—atherosclerosis	1.44e-06	1.69e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AGT—atherosclerosis	1.44e-06	1.68e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.43e-06	1.68e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOS3—atherosclerosis	1.42e-06	1.66e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—APOE—atherosclerosis	1.41e-06	1.65e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—APOB—atherosclerosis	1.41e-06	1.65e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.4e-06	1.64e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—atherosclerosis	1.4e-06	1.64e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CAV1—atherosclerosis	1.4e-06	1.64e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—APOA1—atherosclerosis	1.39e-06	1.63e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MTHFR—atherosclerosis	1.39e-06	1.63e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARG—atherosclerosis	1.38e-06	1.62e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.38e-06	1.62e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MTHFR—atherosclerosis	1.38e-06	1.62e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—atherosclerosis	1.38e-06	1.61e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—LPL—atherosclerosis	1.38e-06	1.61e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.37e-06	1.61e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—atherosclerosis	1.37e-06	1.6e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—atherosclerosis	1.37e-06	1.6e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.37e-06	1.6e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.36e-06	1.6e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARA—atherosclerosis	1.36e-06	1.59e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—INS—atherosclerosis	1.36e-06	1.59e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—LIPC—atherosclerosis	1.36e-06	1.59e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARA—atherosclerosis	1.35e-06	1.59e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—atherosclerosis	1.35e-06	1.58e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOC3—atherosclerosis	1.35e-06	1.58e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—LPL—atherosclerosis	1.34e-06	1.57e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GPX1—atherosclerosis	1.34e-06	1.57e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—LDLR—atherosclerosis	1.34e-06	1.57e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARG—atherosclerosis	1.33e-06	1.56e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AGT—atherosclerosis	1.32e-06	1.54e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—APOB—atherosclerosis	1.31e-06	1.54e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AGT—atherosclerosis	1.31e-06	1.54e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GPX1—atherosclerosis	1.31e-06	1.53e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CETP—atherosclerosis	1.31e-06	1.53e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CD36—atherosclerosis	1.31e-06	1.53e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—INS—atherosclerosis	1.3e-06	1.53e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARG—atherosclerosis	1.3e-06	1.52e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—APOE—atherosclerosis	1.29e-06	1.51e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—APOE—atherosclerosis	1.28e-06	1.5e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CAV1—atherosclerosis	1.28e-06	1.5e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.28e-06	1.5e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—APOA1—atherosclerosis	1.28e-06	1.5e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—INS—atherosclerosis	1.28e-06	1.5e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CD36—atherosclerosis	1.28e-06	1.49e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CAV1—atherosclerosis	1.27e-06	1.49e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—atherosclerosis	1.27e-06	1.49e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—APOA1—atherosclerosis	1.27e-06	1.49e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—LPL—atherosclerosis	1.25e-06	1.47e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.25e-06	1.47e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—atherosclerosis	1.24e-06	1.46e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.24e-06	1.45e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARG—atherosclerosis	1.23e-06	1.44e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GPX1—atherosclerosis	1.22e-06	1.43e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARA—atherosclerosis	1.22e-06	1.42e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MTHFR—atherosclerosis	1.21e-06	1.42e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—INS—atherosclerosis	1.2e-06	1.41e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—atherosclerosis	1.2e-06	1.4e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CD36—atherosclerosis	1.19e-06	1.4e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NOS3—atherosclerosis	1.19e-06	1.39e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARA—atherosclerosis	1.19e-06	1.39e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.18e-06	1.39e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AGT—atherosclerosis	1.18e-06	1.38e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HMOX1—atherosclerosis	1.17e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—atherosclerosis	1.17e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—atherosclerosis	1.17e-06	1.37e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—atherosclerosis	1.16e-06	1.36e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—APOE—atherosclerosis	1.15e-06	1.35e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AGT—atherosclerosis	1.15e-06	1.35e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NOS3—atherosclerosis	1.14e-06	1.34e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CAV1—atherosclerosis	1.14e-06	1.34e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—APOA1—atherosclerosis	1.14e-06	1.33e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—atherosclerosis	1.13e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.13e-06	1.32e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—APOE—atherosclerosis	1.13e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARG—atherosclerosis	1.13e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—APOB—atherosclerosis	1.12e-06	1.31e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NOS3—atherosclerosis	1.12e-06	1.31e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARG—atherosclerosis	1.12e-06	1.31e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CAV1—atherosclerosis	1.12e-06	1.31e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—APOA1—atherosclerosis	1.11e-06	1.3e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARA—atherosclerosis	1.11e-06	1.3e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—INS—atherosclerosis	1.1e-06	1.29e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—atherosclerosis	1.1e-06	1.29e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—INS—atherosclerosis	1.1e-06	1.29e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—atherosclerosis	1.09e-06	1.28e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—atherosclerosis	1.09e-06	1.28e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AGT—atherosclerosis	1.07e-06	1.26e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—LPL—atherosclerosis	1.07e-06	1.26e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—atherosclerosis	1.07e-06	1.25e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—NOS3—atherosclerosis	1.06e-06	1.24e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—atherosclerosis	1.05e-06	1.23e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.05e-06	1.23e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—APOE—atherosclerosis	1.05e-06	1.23e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GPX1—atherosclerosis	1.05e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—atherosclerosis	1.05e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—atherosclerosis	1.04e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CAV1—atherosclerosis	1.04e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.04e-06	1.22e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—atherosclerosis	1.04e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—APOA1—atherosclerosis	1.04e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—atherosclerosis	1.02e-06	1.2e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CD36—atherosclerosis	1.02e-06	1.19e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.02e-06	1.19e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—atherosclerosis	1.01e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—atherosclerosis	1.01e-06	1.18e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARG—atherosclerosis	1e-06	1.18e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—INS—atherosclerosis	9.85e-07	1.15e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARG—atherosclerosis	9.81e-07	1.15e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—atherosclerosis	9.73e-07	1.14e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK3—atherosclerosis	9.68e-07	1.13e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NOS3—atherosclerosis	9.68e-07	1.13e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—atherosclerosis	9.66e-07	1.13e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MTHFR—atherosclerosis	9.65e-07	1.13e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NOS3—atherosclerosis	9.63e-07	1.13e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—INS—atherosclerosis	9.62e-07	1.13e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—atherosclerosis	9.49e-07	1.11e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARA—atherosclerosis	9.47e-07	1.11e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—atherosclerosis	9.39e-07	1.1e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AGT—atherosclerosis	9.17e-07	1.07e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARG—atherosclerosis	9.16e-07	1.07e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HMOX1—atherosclerosis	9.05e-07	1.06e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—atherosclerosis	9.03e-07	1.06e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—APOE—atherosclerosis	8.99e-07	1.05e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—INS—atherosclerosis	8.98e-07	1.05e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CAV1—atherosclerosis	8.9e-07	1.04e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—APOA1—atherosclerosis	8.88e-07	1.04e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—atherosclerosis	8.85e-07	1.04e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—atherosclerosis	8.82e-07	1.03e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—atherosclerosis	8.8e-07	1.03e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOB—atherosclerosis	8.67e-07	1.01e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NOS3—atherosclerosis	8.64e-07	1.01e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—atherosclerosis	8.45e-07	9.9e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NOS3—atherosclerosis	8.43e-07	9.87e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—atherosclerosis	8.43e-07	9.87e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—LPL—atherosclerosis	8.27e-07	9.69e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—atherosclerosis	8.24e-07	9.64e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—atherosclerosis	8.15e-07	9.54e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—atherosclerosis	8.11e-07	9.5e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GPX1—atherosclerosis	8.07e-07	9.45e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—atherosclerosis	7.9e-07	9.25e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NOS3—atherosclerosis	7.88e-07	9.23e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CD36—atherosclerosis	7.86e-07	9.21e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARG—atherosclerosis	7.83e-07	9.17e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—atherosclerosis	7.71e-07	9.03e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—INS—atherosclerosis	7.68e-07	8.99e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTHFR—atherosclerosis	7.45e-07	8.72e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARA—atherosclerosis	7.31e-07	8.56e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—atherosclerosis	7.21e-07	8.44e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AGT—atherosclerosis	7.08e-07	8.29e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—atherosclerosis	7.08e-07	8.29e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—atherosclerosis	7.04e-07	8.24e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOE—atherosclerosis	6.94e-07	8.12e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—atherosclerosis	6.89e-07	8.07e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CAV1—atherosclerosis	6.87e-07	8.05e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—APOA1—atherosclerosis	6.86e-07	8.03e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NOS3—atherosclerosis	6.73e-07	7.88e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—atherosclerosis	6.53e-07	7.65e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—atherosclerosis	6.26e-07	7.33e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—atherosclerosis	6.16e-07	7.21e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARG—atherosclerosis	6.04e-07	7.07e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—INS—atherosclerosis	5.93e-07	6.94e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—atherosclerosis	5.47e-07	6.4e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—atherosclerosis	5.43e-07	6.36e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—atherosclerosis	5.26e-07	6.15e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NOS3—atherosclerosis	5.2e-07	6.08e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—atherosclerosis	5.15e-07	6.03e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—atherosclerosis	4.85e-07	5.68e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.75e-07	5.56e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—atherosclerosis	4.45e-07	5.21e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—atherosclerosis	4.42e-07	5.18e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—atherosclerosis	3.97e-07	4.65e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—atherosclerosis	3.88e-07	4.54e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—atherosclerosis	3.62e-07	4.24e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—atherosclerosis	3.09e-07	3.62e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—atherosclerosis	2.39e-07	2.8e-06	CbGpPWpGaD
